ArticleHeliyon2024
Improving automatic segmentation of liver tumor images using a deep learning model.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
- Chinese expert concern and consensus on applications of artificial intelligence in clinical cancer imaging.Insights into imaging · 2026Article
- Self-Supervised Transformer-Based Pipeline for Liver Tumor Segmentation and Type Classification.JCO clinical cancer informatics · 2026Article
- Current State of Evidence for Use of MRI in LI-RADS.Journal of magnetic resonance imaging : JMRI · 2025Review
- Accurate and robust segmentation of cerebral distal small arteries by DVNet with dual contextual path and vascular attention enhancement.Quantitative imaging in medicine and surgery · 2025Article
- Artificial intelligence techniques in liver cancer.Frontiers in oncology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver tumors are one of the most aggressive malignancies in the human body. Computer-aided technology and liver interventional surgery are effective in the prediction, identification and management of liver neoplasms. One of the important processes is to accurately grasp the morphological structure of the liver and liver blood vessels. However, accurate identification and segmentation of hepatic blood vessels in CT images poses a formidable challenge. Manually locating and segmenting liver vessels in CT images is time-consuming and impractical. There is an imperative clinical requirement for a precise and effective algorithm to segment liver vessels. In response to this demand, the current paper advocates a liver vessel segmentation approach that employs an enhanced 3D fully convolutional neural network V-Net. The network model improves the basic network structure according to the characteristics of liver vessels. First, a pyramidal convolution block is introduced between the encoder and decoder of the network to improve the network localization ability. Then, multi-resolution deep supervision is introduced in the network, resulting in more robust segmentation. Finally, by fusing feature maps of different resolutions, the overall segmentation result is predicted. Evaluation experiments on public datasets demonstrate that our improved scheme can increase the segmentation ability of existing network models for liver vessels. Compared with the existing work, the experimental outcomes demonstrate that the technique presented in this manuscript has attained superior performance on the Dice Coefficient index, which can promote the treatment of liver tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.